Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer
Clinical trial NCT03225547 · TERMINATED
Trial details
- NCT number
- NCT03225547
- Sponsor
- University of Chicago
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-12
- Primary completion
- 2025-09-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.